Piroze Minoo Davierwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Piroze Minoo Davierwala has a total of 208 co-authors. Here are the top co-authors by number of shared publications:
Martin Misfeld
Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany
15 shared publications- Michael Andrew Borger
University Department of Cardiac Surgery, Leipzig Heart Center, Germany (A.v.K., M.A.B.).
10 shared publications Alexander Verevkin
Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany
7 shared publicationsFriedrich W. Mohr
From Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany (P.M.D., S.L., A.V., F.B., M. Misfeld, F.W.M.); Department of Cardiovascular Surgery, Heart and Circulatory Center, Rotenburg an der Fulda, Germany (A.J.R.); and Medizinische Klinik II, Sana Kliniken, Lübeck, Germany (M. Mohr)
7 shared publicationsSergey Leontyev
University Department for Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany
6 shared publications- Josephina Haunschild
Department of Cardiac Surgery, Heart Center Leipzig, University of Leipzig, 04289 Leipzig, Germany
5 shared publications
Latest Publications
- Open Access
- 6 August 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (22) , 104631
Minimally Invasive Redo-Coronary Artery Bypass Grafting to the Left Anterior Descending Artery
- 6 August 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (22) , 104631
Open AccessMinimally Invasive Redo-Coronary Artery Bypass Grafting to the Left Anterior Descending Artery
- 19 December 2024
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 170 (4) , 1096-1097
Commentary: Going small should not—and does not—compromise quality
- 19 December 2024
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 170 (4) , 1096-1097
Commentary: Going small should not—and does not—compromise quality
- Open Access
- 24 October 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
Ten-year survival benefit and appropriateness of surgical versus percutaneous revascularization in synergy between percutaneous coronary intervention with Taxus and cardiac surgery randomized trial
OBJECTIVES: Average treatment effects from randomized trials do not reflect the heterogeneity of an individual’s response to treatment. This study evaluates the appropriate proportions of patients for coronary artery bypass grafting, or percutaneous intervention based on the predicted/observed ratio of 10-year all-cause mortality in the SYNTAX population. METHODS: The study included 1800 randomized patients and 1275 patients in the nested percutaneous (n = 198) or surgical (n = 1077) registries. The primary end point was 10-year all-cause mortality. The SYNTAX score II-2020 was validated internally in the randomized cohort and externally in the registry cohort. Proportions of patients with survival benefits from coronary artery bypass grafting or percutaneous intervention were determined using SYNTAX score II-2020. RESULTS: Ten-year mortality was 23.8% for coronary artery bypass grafting, 28.6% for percutaneous intervention in the randomized cohort, 27.6% for coronary artery bypass grafting and 55.4% for percutaneous intervention in the registries. In the coronary artery bypass grafting registry, the SYNTAX score II-2020 predicted 10-year mortality with helpful calibration and discrimination (C-index: 0.70, intercept: 0.00, slope: 0.76). The proportion of patients deriving a predicted survival benefit from coronary artery bypass grafting over percutaneous intervention was 82.4% (2143/2602) and 17.7% (459/2602) for the entire SYNTAX trial population, translating into a 4.7 to 1 appropriate ratio of treatment allocation to coronary artery bypass grafting and percutaneous intervention. CONCLUSIONS: Choosing a revascularization modality should depend on an individual’s long-term prognosis rather than average treatment effects. Additionally, patients should be informed about their predicted prognosis. Trial registration: Registered on clinicaltrial.gov SYNTAXES: NCT03417050 (https://clinicaltrials.gov/ct2/show/NCT03417050) SYNTAX: NCT00114972 (https://www.clinicaltrials.gov/ct2/show/NCT00114972)
- 24 October 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
Open AccessTen-year survival benefit and appropriateness of surgical versus percutaneous revascularization in synergy between percutaneous coronary intervention with Taxus and cardiac surgery randomized trial
OBJECTIVES: Average treatment effects from randomized trials do not reflect the heterogeneity of an individual’s response to treatment. This study evaluates the appropriate proportions of patients for coronary artery bypass grafting, or percutaneous intervention based on the predicted/observed ratio of 10-year all-cause mortality in the SYNTAX population. METHODS: The study included 1800 randomized patients and 1275 patients in the nested percutaneous (n = 198) or surgical (n = 1077) registries. The primary end point was 10-year all-cause mortality. The SYNTAX score II-2020 was validated internally in the randomized cohort and externally in the registry cohort. Proportions of patients with survival benefits from coronary artery bypass grafting or percutaneous intervention were determined using SYNTAX score II-2020. RESULTS: Ten-year mortality was 23.8% for coronary artery bypass grafting, 28.6% for percutaneous intervention in the randomized cohort, 27.6% for coronary artery bypass grafting and 55.4% for percutaneous intervention in the registries. In the coronary artery bypass grafting registry, the SYNTAX score II-2020 predicted 10-year mortality with helpful calibration and discrimination (C-index: 0.70, intercept: 0.00, slope: 0.76). The proportion of patients deriving a predicted survival benefit from coronary artery bypass grafting over percutaneous intervention was 82.4% (2143/2602) and 17.7% (459/2602) for the entire SYNTAX trial population, translating into a 4.7 to 1 appropriate ratio of treatment allocation to coronary artery bypass grafting and percutaneous intervention. CONCLUSIONS: Choosing a revascularization modality should depend on an individual’s long-term prognosis rather than average treatment effects. Additionally, patients should be informed about their predicted prognosis. Trial registration: Registered on clinicaltrial.gov SYNTAXES: NCT03417050 (https://clinicaltrials.gov/ct2/show/NCT03417050) SYNTAX: NCT00114972 (https://www.clinicaltrials.gov/ct2/show/NCT00114972)
- 9 August 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (5) , 1044-1051
Total Arterial Multivessel Minimally Invasive Coronary Artery Bypass Surgery: 5-Year Outcomes
- 9 August 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (5) , 1044-1051
Total Arterial Multivessel Minimally Invasive Coronary Artery Bypass Surgery: 5-Year Outcomes
- Open Access
The Feasibility of Less-Invasive Bentall Surgery: A Real-World Analysis
Objective: Minimally invasive approaches are being used increasingly in cardiac surgery and applied in a wider range of operations, including complex aortic procedures. The aim of this study was to examine the safety and feasibility of a partial upper sternotomy approach for isolated elective aortic root replacement (a modified Bentall procedure). Methods: We performed a retrospective analysis of 768 consecutive patients who had undergone isolated Bentall surgery between January 2000 and January 2021 at our institution, with the exclusion of re-operations, endocarditis, acute aortic dissections, and root replacement with major concomitant procedures such as multi-valve or coronary bypass surgery. A total of 98 patients were operated on via partial sternotomy (PS) and were matched 2:1 to 196 patients operated on via full sternotomy (FS). Results: The procedure time was 12 min longer in the PS group (205 min vs. 192.5 min in the FS group, p = 0.002), however, cardiopulmonary bypass and aortic cross-clamp times were comparable between groups. Eight PS-procedures were converted to full sternotomy, predominantly for bleeding complications (n = 6). Re-exploration for acute bleeding was necessary in 11% of the PS group and 4.1% of the FS group (p = 0.02). Five FS patients and none in the PS group required emergency coronary bypass grafting for postoperative coronary obstruction (p = 0.2). PS patients were hospitalized for a significantly shorter period (9.5 days vs. 10.5 days in the FS group, respectively). There were no significant differences regarding in-hospital (p = 0.4) and mid-term mortality (p = 0.73), as well as for other perioperative complications. Conclusions: Performing Bentall operations via partial upper sternotomy is associated with similar perfusion and cross-clamp times, as well as overall mortality, when compared to a full sternotomy approach. A low threshold for conversion to full sternotomy should be accepted if limited access proves insufficient for the handling of intraoperative complications, particularly bleeding.
Open AccessThe Feasibility of Less-Invasive Bentall Surgery: A Real-World Analysis
Objective: Minimally invasive approaches are being used increasingly in cardiac surgery and applied in a wider range of operations, including complex aortic procedures. The aim of this study was to examine the safety and feasibility of a partial upper sternotomy approach for isolated elective aortic root replacement (a modified Bentall procedure). Methods: We performed a retrospective analysis of 768 consecutive patients who had undergone isolated Bentall surgery between January 2000 and January 2021 at our institution, with the exclusion of re-operations, endocarditis, acute aortic dissections, and root replacement with major concomitant procedures such as multi-valve or coronary bypass surgery. A total of 98 patients were operated on via partial sternotomy (PS) and were matched 2:1 to 196 patients operated on via full sternotomy (FS). Results: The procedure time was 12 min longer in the PS group (205 min vs. 192.5 min in the FS group, p = 0.002), however, cardiopulmonary bypass and aortic cross-clamp times were comparable between groups. Eight PS-procedures were converted to full sternotomy, predominantly for bleeding complications (n = 6). Re-exploration for acute bleeding was necessary in 11% of the PS group and 4.1% of the FS group (p = 0.02). Five FS patients and none in the PS group required emergency coronary bypass grafting for postoperative coronary obstruction (p = 0.2). PS patients were hospitalized for a significantly shorter period (9.5 days vs. 10.5 days in the FS group, respectively). There were no significant differences regarding in-hospital (p = 0.4) and mid-term mortality (p = 0.73), as well as for other perioperative complications. Conclusions: Performing Bentall operations via partial upper sternotomy is associated with similar perfusion and cross-clamp times, as well as overall mortality, when compared to a full sternotomy approach. A low threshold for conversion to full sternotomy should be accepted if limited access proves insufficient for the handling of intraoperative complications, particularly bleeding.
- Open Access
- 1 July 2023
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 9, 40
The current role and future perspectives of minimally invasive coronary artery bypass grafting
Editorial Commentary: Cardiac Surgery The current role and future perspectives of minimally invasive coronary artery bypass grafting German Alberto Fortunato, Piroze M. Davierwala
- 1 July 2023
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 9, 40
Open AccessThe current role and future perspectives of minimally invasive coronary artery bypass grafting
Editorial Commentary: Cardiac Surgery The current role and future perspectives of minimally invasive coronary artery bypass grafting German Alberto Fortunato, Piroze M. Davierwala
- 1 June 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 63 (6)
Complicated endocarditis—to spare or not to spare the mitral valve
Infective endocarditis involving the native or prosthetic aortic valve presents itself through a myriad of pathological features ranging from vegetations to perforations to complete cusp destruction with or without annular and/or periannular extension. The clinical presentation of the patient is not only determined by the systemic effects of bacteraemia, septic emboli and sepsis but also the haemodynamic consequences of intracardiac lesions such as valve insufficiency and intracardiac fistulas and in some cases septic cardiomyopathy. Therefore, patients presenting for surgery may either be very sick due to the systemic manifestation of the infection or pose a technical challenge due to the complicated nature of the intracardiac pathology or in the worst-case scenario, both. The type of surgery depends on the extent of involvement of the aortic valve and perivalvular structures. When infection is limited to the aortic cusps, conventional valve repair techniques or more commonly replacement are usually sufficient to adequately address the infection. However, perivalvular extension of the infective process frequently involves the fibrous annulus of the aortic valve, often spreading to the intervalvular fibrous body (IFB) and further on to the anterior mitral leaflet (AML). Such patients require the so-called Commando/UFO operation, first developed by the Toronto group, which involves radical resection of all macroscopically infected tissues including the aortic valve or prosthesis, the IFB, and the mitral valve, particularly if a substantial portion of the AML is involved. This is followed by aortic and mitral valve replacement and reconstruction of the IFB with a 2-tongued bovine pericardial or Dacron patch [ 1–3]. Sometimes, however, only a small segment of the base of the AML is affected. In such situations, the so-called Hemi-commando operation described by the Cleveland clinic group, which involves replacement of the aortic valve/root and the IFB, while sparing the mitral valve, is performed [ 4].
- 1 June 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 63 (6)
Complicated endocarditis—to spare or not to spare the mitral valve
Infective endocarditis involving the native or prosthetic aortic valve presents itself through a myriad of pathological features ranging from vegetations to perforations to complete cusp destruction with or without annular and/or periannular extension. The clinical presentation of the patient is not only determined by the systemic effects of bacteraemia, septic emboli and sepsis but also the haemodynamic consequences of intracardiac lesions such as valve insufficiency and intracardiac fistulas and in some cases septic cardiomyopathy. Therefore, patients presenting for surgery may either be very sick due to the systemic manifestation of the infection or pose a technical challenge due to the complicated nature of the intracardiac pathology or in the worst-case scenario, both. The type of surgery depends on the extent of involvement of the aortic valve and perivalvular structures. When infection is limited to the aortic cusps, conventional valve repair techniques or more commonly replacement are usually sufficient to adequately address the infection. However, perivalvular extension of the infective process frequently involves the fibrous annulus of the aortic valve, often spreading to the intervalvular fibrous body (IFB) and further on to the anterior mitral leaflet (AML). Such patients require the so-called Commando/UFO operation, first developed by the Toronto group, which involves radical resection of all macroscopically infected tissues including the aortic valve or prosthesis, the IFB, and the mitral valve, particularly if a substantial portion of the AML is involved. This is followed by aortic and mitral valve replacement and reconstruction of the IFB with a 2-tongued bovine pericardial or Dacron patch [ 1–3]. Sometimes, however, only a small segment of the base of the AML is affected. In such situations, the so-called Hemi-commando operation described by the Cleveland clinic group, which involves replacement of the aortic valve/root and the IFB, while sparing the mitral valve, is performed [ 4].
- 17 May 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (12) , 1231-1242
Predicted and Observed Mortality at 10 Years in Patients With Bifurcation Lesions in the SYNTAX Trial
- 17 May 2022
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 15 (12) , 1231-1242
Predicted and Observed Mortality at 10 Years in Patients With Bifurcation Lesions in the SYNTAX Trial